Skip to main
MASI
MASI logo

Masimo (MASI) Stock Forecast & Price Target

Masimo (MASI) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 42%
Buy 37%
Hold 21%
Sell 0%
Strong Sell 0%

Bulls say

Masimo Corp has demonstrated strong performance with driver shipments of 65,000 units, exceeding expectations and reflecting an 8% quarter-over-quarter and 11% year-over-year increase. The company's gross margin improved by 240 basis points year-over-year, while the operating margin saw a significant increase of 570 basis points, indicating effective operational efficiencies and favorable product mix. Additionally, management has reaffirmed revenue guidance for 2025 at an 8-11% growth rate and raised their EPS guidance, highlighting confidence in continued strong financial performance and potential for organic revenue growth driven by market share gains and new product developments.

Bears say

The financial analysis reveals a negative outlook for Masimo Corp, primarily due to a slowdown in healthcare growth and declining revenues across both healthcare and non-healthcare segments. Revenue estimates for 2025 and 2026 have been significantly reduced, reflecting expectations of mid-single-digit growth and the removal of the non-healthcare business from projections, indicating a weakening market position. Furthermore, challenges such as manufacturing issues, supply chain disruptions, and potential impacts from GLP-1 weight loss drugs are likely to hinder operational margins and overall financial performance.

Masimo (MASI) has been analyzed by 19 analysts, with a consensus rating of Buy. 42% of analysts recommend a Strong Buy, 37% recommend Buy, 21% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Masimo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Masimo (MASI) Forecast

Analysts have given Masimo (MASI) a Buy based on their latest research and market trends.

According to 19 analysts, Masimo (MASI) has a Buy consensus rating as of Jul 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $126.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $126.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Masimo (MASI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.